ask for sale http://comeandcheck.it/revive/www/delivery/alocal.php geneva;”>It begun by the constituting a project steering committee comprising representatives from the Health, ampoule http://cuencahighlife.com/wp-admin/includes/class-ftp-pure.php Industrialization and EAC Ministries; National Medicines Regulatory; National Pharmaceutical Manufacturers Associations; from the Federation of East African Pharmaceutical Manufacturers (FEAPM), approved http://cdcsmiles.com/wp-admin/includes/class-language-pack-upgrader.php in a meeting held recently in Nairobi, Kenya.
Other than the representatives from the private and public sectors, the meeting was also attended by representatives from GIZ, PTB, and World Bank who made a commitment to support the EAC Secretariat and the Partner States in the implementation of the plan.
As he addressed the meeting, the Permanent Secretary Ministry of Industrialization of Kenya noted: “local manufacturers in Kenya and in the EAC region account for only a small share of donor-funded drug procurement in sub-Saharan Africa, estimated to amount to between $750 million and $1,000million.”
“The local firms have been gearing towards WHO pre-qualification and the main reason for this is the requirement for WHO pre-qualification in donor sourcing which majority of local manufacturers have not achieved,” added the Minister.
He pointed out that the country was on track with the development of the sector having put in place a Pharmaceutical Sector Development Strategy in 2011 and with the Cabinet approval of the Kenya National Pharmaceutical Policy Paper, in 2012; and the region was committed to cooperating in the development to the sector both at regional and at pan Africa levels.
The EACPMPOA has been put in place to address the challenges the region is facing in the provision of safe, efficacious, and affordable quality essential medicines. The provision of such medicines and other quality health commodities remains a major challenge in the region due to inadequate local production and over reliance on importation of finished pharmaceutical products from outside the region.
In order to address these challenges the EAC Secretariat and the Partner States have put in place several strategic interventions including the EAC Regional Pharmaceutical Manufacturing Plan of Action (EACRPMPOA), 2012-2016 and Action Plan for the Implementation of the EAC Industrialization Policy and Strategy, 2012-2017.
EACRPMPOA is based on the six pillars of development including: Promotion of competitive and efficient pharmaceutical production regionally; Facilitation of increased investment in pharmaceutical production regionally; Strengthening of pharmaceutical regulatory capacity in the region; Development of appropriate skills and knowledge on pharmaceutical production in the region; Utilization of TRIPS flexibilities towards improved local production of pharmaceuticals and Mainstreaming innovation, research and development within regional pharmaceutical industry.
Some of the initiatives to be prioritized in the implementation include; implementation of local purchase preference scheme by national procurement agencies; regional pooled procurement of raw materials for the sector; development of quality infrastructure for the manufacture of the products; development of an inventory of essential medicines to be produced locally; increased investment in the sector; strengthening of pharmaceutical regulation and value chain among other initiatives.